DGIST’s research Team has clarified the fundamentals of coiled toxin protein which causes neurodegenerative brain disorders
A research team led by Professor Sung Bae Lee of Brain and Cognitive Sciences and Professor Daehee Hwang of New Biology (Vice-head of the Plant Age and Life Research Group, IBS) has identified the early neuropathology mechanism of structural characteristics of polyglutamine toxic protein on neurodegenerative brain disorders. It was through a joint research with Professor Yuh Nung Jan at the Howards Hughes Medical Institute (HHMI) in the U.S.
The number of patients with neurodegenerative disorders is growing rapidly as humans’ life expectancy is increasing. Although many scholars are devoted into researching the pathogenesis and the advancement of neurodegenerative brain disorders, not much has been identified yet. There is still too much work left to develop an actual treatment since it is difficult to diagnose the disease early.
In this study, the researchers identified that coiled-coil structure of polyglutamine toxic protein, which is like an entangled telephone wire, causes the rapid deformation of neuron and early neurodegenerative diseases, such as Huntington’s chorea and spino-cerebellar ataxias.
Proteins have abnormal combinations with each other to form the coiled-coil structure of polyglutamine toxic protein. The research team discovered that the coiled-coil structure of polyglutamine toxic protein inside neurons cause early neuropathy by combining with ‘Foxo protein’, which is adjusts the formation of dendrite, as a transcription factor.
While the research focused on Foxo protein as the first factor of the early symptom of neurodegenerative brain disorders, it also predicted that other factors would exist. The research team thus expected to be able to speed the related studies in the future by focusing on clarifying additional factors based on this research.
Professor Lee said “The core of this research is that the coiled-coil structure of toxin protein that causes degenerative brain disorders entangle with the coiled-coil structure of other protein, which is an important cause of early neurodegenerative diseases. By developing a treatment targeting the entanglement based on coiled-coil structure through this research, we expect to be able to have effective treatments to alleviate the early symptoms of neurodegenerative brain disorders”
Learn more: A New Hope in Treating Neurodegenerative Disease
The Latest on: Neurodegenerative brain disorders
via Google News
The Latest on: Neurodegenerative brain disorders
- Simple molecular reagents to treat Alzheimer's diseaseon May 11, 2020 at 6:32 am
Sometimes the most complex problems actually have very simple solutions. A group of South Korean researchers reported an efficient and effective redox-based strategy for incorporating multiple ...
- Recent Research into Neurodegenerative Diseaseson May 11, 2020 at 2:01 am
Research into neurodegenerative diseases are important as these diseases follow only cardiovascular diseases and cancer as primary causes of death.
- This study discovers a new chronic brain disorderon May 10, 2020 at 3:30 am
A recent study led by Murdoch Children’s Research Institute reported a new brain disorder in which children experience developmental regression and severe epilepsy. The team found a gene variation ...
- Aluminium in human brain tissue from donors without neurodegenerative disease: A comparison with Alzheimer’s disease, multiple sclerosis and autismon May 8, 2020 at 7:16 am
A burgeoning number of studies are demonstrating aluminium in human brain tissue. While research has both quantified and imaged aluminium in human brain tissue in neurodegenerative and ...
- Targeting early brain inflammation may slow down Alzheimer’son May 7, 2020 at 8:54 am
Research in animal models suggests rebalancing early brain inflammation may slow the progression of Alzheimer’s disease. The new study was on the agenda of the American Association for Anatomy (AAA) ...
- A 3D human brain–like tissue model of herpes-induced Alzheimer’s diseaseon May 6, 2020 at 11:23 am
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes cognitive decline, memory loss, and inability to perform everyday functions. Hallmark features of AD—including generation of ...
- 3-D brain-like tissue model links Alzheimer's disease with herpeson May 6, 2020 at 11:01 am
Engineers and scientists led by Tufts University used a three-dimensional (3-D) human tissue culture model mimicking the components and conditions in the brain to demonstrate a possible causal ...
- Biotech Develops Antagonists for Protein Tied to Neurodegenerative Diseaseson May 6, 2020 at 10:57 am
(PMN:TSX; ARFXF:OTCQB) announced in a news release it developed antagonists against the receptor for activated protein kinase C 1 (RACK1), which prevent aggregation of normal brain protein and related ...
- ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous neurodegenerative diseases, including ALSon May 6, 2020 at 3:52 am
ProMIS Neurosciences, Inc. (PMN.TO) (ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of ...
- Global Neurodegenerative Diseases Market 2020 Industry Size, Key Players, Trends, Share, Supply Chain and Analysis and Forecast to 2025on May 4, 2020 at 12:27 am
Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Neurodegenerative Diseases ...
via Bing News